About Cannabichromene (CBC)
Cannabichromene, or CBC, is considered one of the "big six" cannabinoids in ongoing research and has gained a lot of attention for its medical potential. One unique property that differentiates it from other cannabinoids is its ability to bind to receptors beyond those of the endocannabinoid system. Stemming from cannabigerolic acid (CBGA), it converts to carboxylic acid (CBCA) and once it has been decarboxylated due to heat or ultraviolet light exposure, converts to the final CBC compounds taken in by our bodies. With a boiling point of 428 degrees fahrenheit, it is thought to work synergistically with other cannabinoids in what is known as the "entourage effect."
CBC is thought to effect pain perception, effectively reduce inflammation, promote essential brain function, and inhibit tumor growth. In research so far, it has been found that CBC is the second most effective cannabinoid at stopping the growth of new cancer cells. Additionally, CBC shows great promise as a powerful anti-acne treatment, as trials have shown it to be effective in eliminating the cause of acne as well as treating the symptoms. Finally, tests have indicated that CBC may hold promise as a potent anti-depressant, potentially contributing to mood-elevating treatments.
Laboratory test results correlate to strain attributes and subsequently, to the recommendations provided by StrainRx. A strain rich in CBC will result in elevated pain relieving properties and higher values for the reduction of inflammation. Research is ongoing to unlock additional medical benefits of CBC and our data will be updated with new information as it becomes available.
Looking for a high CBC strain? Use our Cannabis Search Engine to find it near you!